GlassScriptPhysician profile
Bhavanadhar Penta
NPI 1669171781
$17,895.27
in general payments reported to CMS, 2019-2025
27 companies · $4,844 in 2025
The $4,844 reported for 2025 was more than what 82% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $2,110 · 2024: $11K · 2025: $4,844.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $13K · Travel and Lodging: $4,206 · Grant: $1,063 · Education: $1.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $12,625.08 |
| Travel and Lodging | $4,205.89 |
| Grant | $1,063.30 |
| Education | $1.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,156.36 | 2023-2025 | Avvigo Guidance System, Comet, Mach1 |
| Edwards Lifesciences Corporation | $2,450.71 | 2024-2025 | Pascal, Sapien 3 Ultra Resilia |
| Shockwave Medical, INC | $2,235.49 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abbott Laboratories | $1,693.84 | 2025 | Amplatzer, Navitor, Amplatzer Amulet |
| Abiomed | $1,406.54 | 2023-2025 | Impella |
| Cardiva Medical, INC. | $1,332.80 | 2023-2025 | Cardiva Vascade 5f Vcs, Cardiva Vascade 6/7f Vcs, Optowire |
| Medtronic, INC. | $1,005.78 | 2024-2025 | Corevalve Evolut R, Ffrangio |
| Terumo Medical Corporation | $726.04 | 2023-2024 | Glidesheath Slender, Azur Cx Detachable, Metacross Otw |
| Biotronik INC. | $664.95 | 2023-2025 | Orsiro Mission, Pantera Leo, Nhancer Rx |
| Chiesi USA, INC. | $593.61 | 2023-2025 | Kengreal |
| Bard Peripheral Vascular, INC. | $515.00 | 2023-2025 | Lutonix Drug Coated Balloon, Rotarexs 6 F X 135 Cm, Lifestent Solo Vascular Stent |
| Teleflex LLC | $492.48 | 2023-2025 | Turnpike, Trapliner, Vascband |
| Cook Medical LLC | $288.90 | 2024-2025 | Icast Covered Stent System, 6mmx22mmx120cm, Zilver Ptx, Cook Celect |
| Amgen INC. | $213.56 | 2024-2025 | Repatha |
| Cordis US Corp. | $205.52 | 2023-2025 | Mynx Control Venous, Mynx Venous Vcd, Zephyr |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $164.40 | 2024-2025 | Angiovac, Alphavac |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $138.49 | 2023-2024 | Lifevest |
| Novartis Pharmaceuticals Corporation | $94.31 | 2024-2025 | |
| Philips North America LLC | $88.07 | 2025 | Coronary Other |
| Asahi Intecc USA, INC. | $87.16 | 2023-2025 | Asahi Ptca Guide Wire, Asahi Peripheral Vascular Wires, Peripheral Vascular |
| Janssen Pharmaceuticals, INC | $86.78 | 2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $61.29 | 2023-2024 | Farxiga |
| Janssen Scientific Affairs, LLC | $44.64 | 2023 | Xarelto |
| Stryker Corporation | $42.51 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Inari Medical, INC. | $42.50 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Imperative Care, INC | $37.96 | 2025 | Prodigy Catheter |
| Zoll Circulation INC | $25.58 | 2024 | Therox Ds2 Console, Catheter, Downstream Cartridge |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bhavanadhar Penta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.